Amyotrophic lateral sclerosis (ALS) is a rapidly progressing, as yet incurable neurodegenerative disease that poses considerable medical, therapeutic and social challenges. Despite its comparatively low prevalence, ALS represents a central issue in neurological research due to its complexity and severity. New findings on molecular pathogenesis, the role of genetic factors and the development of innovative therapeutic strategies open up promising prospects for diagnosis, treatment and care.
Autoren
- Tanja Schliebe
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Severe acute pancreatitis
COX-2 inhibition alleviates inflammation and improves outcomes
- Ulcerative colitis
Rgs14 protein can worsen the severity
- Mastocytosis
Innovative pathogenesis-based therapeutic approaches in the pipeline
- Psychooncology
Communication as the key to therapy adherence
- Participation of the patient
Adherence in psychiatry
- From symptom to diagnosis
Renal cell carcinoma
- Lipid management: ESC/EAS guideline update 2025
New recommendations on CVD risk classification, lipid lowering in statin intolerance and hoFH
- Chronically active MS lesions